Patents by Inventor Karen K. Y. Young

Karen K. Y. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10689718
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: June 23, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Publication number: 20170268074
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Application
    Filed: June 2, 2017
    Publication date: September 21, 2017
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Patent number: 9702017
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: July 11, 2017
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Publication number: 20140363809
    Abstract: The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St. Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3? untranslated region of the viral genomes to be detected.
    Type: Application
    Filed: August 22, 2014
    Publication date: December 11, 2014
    Inventor: Karen K.Y. Young
  • Patent number: 8846312
    Abstract: The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St. Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3? untranslated region of the viral genomes to be detected.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: September 30, 2014
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Karen K. Y. Young
  • Publication number: 20130280697
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Application
    Filed: April 17, 2013
    Publication date: October 24, 2013
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Publication number: 20100041040
    Abstract: The present invention relates to new methods and uses for the detection and quantification of microbial nucleic acids employing an internal quantitative reference. Preferred methods are based on the amplification of nucleic acids, preferably the polymerase chain reaction. Further provided are kits comprising components for performing said methods and uses. Moreover, an analytical system for advantageously performing the method according to the invention is disclosed.
    Type: Application
    Filed: June 5, 2009
    Publication date: February 18, 2010
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Reiner Babiel, Joachim Glaubitz, Lutz Guertler, Dorothea Sizmann, Karen K.Y. Young
  • Publication number: 20090176236
    Abstract: The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St. Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3? untranslated region of the viral genomes to be detected.
    Type: Application
    Filed: December 19, 2008
    Publication date: July 9, 2009
    Applicant: Roche Molecular Systems, Inc.
    Inventor: Karen K.Y. Young
  • Patent number: 7510827
    Abstract: The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, and Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3? untranslated region of the viral genomes to be detected.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: March 31, 2009
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Karen K. Y. Young
  • Publication number: 20040229261
    Abstract: The present invention provides rapid and accurate methods, primers, probes and kits for identifying the presence of a certain flaviviruses in a sample. Flaviviruses that can be detected include members of the Japanese encephalitis virus serogroup, Dengue virus, St. Louis encephalitis virus, Montana myotis leukoencephalitis virus, Modoc virus, ad Yellow Fever virus. The primers and probes of the invention can hybridize to regions in the 3′ untranslated region of the viral genomes to be detected.
    Type: Application
    Filed: March 31, 2004
    Publication date: November 18, 2004
    Applicant: Roche Molecular Systems, Inc.
    Inventor: Karen K.Y. Young
  • Patent number: 5643723
    Abstract: A method is provided for detecting M. tuberculosis or mutants thereof, particularly rifampin-resistant MTB, in a biological sample comprising: isolating DNA from the biological sample; amplifying the isolated DNA under hybridizing conditions with a primer set that targets portions of the gene encoding rpoB; wherein the pimer set comprises at least one primer that hybridizes under hybridizing conditions to at least one signature nucleotide for M. tuberculosis; and isolating and sequencing the amplified DNA to determine the presence or absence of M. tuberculosis or mutants thereof.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: July 1, 1997
    Assignees: Roche Molecular Systems, Inc., Mayo Foundation For Medical Education and Research
    Inventors: David H. Persing, John J. Hunt, Karen K. Y. Young, Teresa A. Felmlee, Glenn D. Roberts, A. Christian Whelan
  • Patent number: 5593836
    Abstract: Primers and probes can be used to detect nucleic acid from human strains of Pneumocystis carinii in a sample. The nucleotide sequence of a region of the 18S ribosomal RNA gene of a strain of P. carinii derived from humans is provided. The primers amplify regions of the 18S ribosomal RNA gene and hybridize to regions containing variability among strains. Probes hybridize to a regions within the amplified region that contain variability among strains.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: January 14, 1997
    Inventors: John T. Niemiec, Karen K. Y. Young
  • Patent number: 5580718
    Abstract: Oligonucleotides primers can be used to amplify and detect Hepatitis C virus nucleic acids in a process that involves reverse transcription of the viral genomic RNA to create cDNA and the subsequent amplification of the cDNA by the polymerase chain reaction. Oligonucleotide probes can be used to detect the presence of amplified DNA by hybridization. The invention provides improved methods, compositions, and kits for amplifying and detecting U.S., Japan, and HCV-C prototype nucleic acids.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: December 3, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert M. Resnick, Karen K. Y. Young
  • Patent number: 5527669
    Abstract: Oligonucleotides primers can be used to amplify and detect Hepatitis C virus nucleic acids in a process that involves reverse transcription of the viral genomic RNA to create cDNA and the subsequent amplification of the cDNA by the polymerase chain reaction. Oligonucleotide probes can be used to detect the presence of amplified DNA by hybridization. The invention provides improved methods, compositions, and kits for amplifying and detecting U.S., Japan, and HCV-C prototype nucleic acids.
    Type: Grant
    Filed: May 10, 1994
    Date of Patent: June 18, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Robert M. Resnick, Karen K. Y. Young
  • Patent number: 5422242
    Abstract: Primers and probes can be used to detect nucleic acid from Mycobacterium in a sample and determine the species from which the nucleic acid originates. The primers amplify regions of the 16S ribosomal RNA gene and hybridize to regions conserved among species. Genus specific probes hybridize to sequences within the amplified region conserved among mycobacterial species, whereas the species specific probes hybridize to a variable region, so that the species identity can be uniquely determined. Consensus probes for detecting mycobacteria nucleic acids are provided which probes are not identical to any of the sequences of mycobacterial species.
    Type: Grant
    Filed: July 17, 1992
    Date of Patent: June 6, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Karen K. Y. Young